Key result
Withdrawal of calcium channel blockers was associated with reduced systolic blood pressure control (RR 0.89) and an increase in systolic blood pressure compared to usual care.
Why the study?
Deprescribing of antihypertensive drugs is recommended for some older patients with polypharmacy, but evidence is lacking on which drug class or dose to withdraw.
Does withdrawal of specific antihypertensive drug classes or doses affect systolic blood pressure control and adverse events in older patients with polypharmacy?
RCT (n=569)
Open-label
1:1 allocation ratio using a non-deterministic minimization algorithm
Yes
Does withdrawal of specific antihypertensive drug classes or doses affect systolic blood pressure control and adverse events in older patients with polypharmacy?
Relative Risk: 0.89 (95% CI 0.8–0.998)
In older patients with polypharmacy, deprescribing higher-dose calcium channel blockers reduces blood pressure control, whereas low-dose beta-blockers can be safely withdrawn without significant blood pressure changes over 12 weeks.
May avoid higher-dose CCB withdrawal to preserve BP control; leaves open confirmatory trials before changing deprescribing priorities.
Aims: Deprescribing of antihypertensive drugs is recommended for some older patients with polypharmacy, but there is little evidence to inform which drug (or dose) should be withdrawn. This study used data from the OPTiMISE trial to examine whether short-term outcomes of deprescribing vary by drug class and dose of medication withdrawn. Methods: The OPTiMISE trial included patients aged ≥80 years with controlled systolic blood pressure (SBP; <150 mmHg), receiving ≥2 antihypertensive medications. This study compared SBP control, mean change in SBP and frequency of adverse events after 12 weeks in participants stopping one medication vs. usual care, by drug class and equivalent dose of medication withdrawn. Equivalent dose was determined according to the defined daily dose (DDD) of each medication type. Drugs prescribed below the DDD were classed as low dose and those prescribed at ≥DDD were described as higher dose. Outcomes were examined by generalized linear mixed effects models. Results: A total of 569 participants were randomized, aged 85 ± 3 years with controlled blood pressure (mean 130/69 mmHg). Within patients prescribed calcium channel blockers, higher dose medications were more commonly selected for withdrawal (90 vs. 10%). In those prescribed beta-blockers, low dose medications were more commonly chosen (87 vs. 13%). Withdrawal of calcium channel blockers was associated with an increase in SBP (5 mmHg, 95%CI 0–10 mmHg) and reduced SBP control (adjusted RR 0.89, 95%CI 0.80–0.998) compared to usual care. In contrast, withdrawal of beta-blockers was associated with no change in SBP (−4 mmHg, 95%CI −10 to 2 mmHg) and no difference in SBP control (adjusted RR 1.15, 95%CI 0.96–1.37). Similarly, withdrawal of higher dose medications was associated with an increase in SBP but no change in BP control. Withdrawal of lower dose medications was not associated with a difference in SBP or SBP control. There was no association between withdrawal of specific drug classes and adverse events. Conclusion: These exploratory data suggest withdrawal of higher dose calcium channel blockers should be avoided if the goal is to maintain BP control. However, low dose beta-blockers may be removed with little impact on blood pressure over 12-weeks of follow-up. Larger studies are needed to confirm these associations.
No takes yet. Share an insight, caveat, or question.
Sheppard et al. (2021) conducted an RCT in Controlled systolic hypertension with polypharmacy (n=569). Antihypertensive medication reduction (withdrawal of one medication) vs. Usual care (continuation of medications) was evaluated on Systolic blood pressure control at 12 weeks (calcium channel blocker withdrawal subgroup) (RR 0.89, 95% CI 0.80-0.998). Withdrawal of calcium channel blockers was associated with reduced systolic blood pressure control (RR 0.89) and an increase in systolic blood pressure compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: